₹ 5.0 Cr
Volume transacted
58.5 K
stocks traded
Last Updated time: 19 Sep 9.00 AM
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price | Day Open | Day High | Day Low |
---|
19 Sep 2024 | 847.35 | 919 | 922.05 | 835 |
18 Sep 2024 | 904.6 | 890.85 | 959.95 | 883.65 |
17 Sep 2024 | 891.8 | 885.1 | 898.05 | 875 |
16 Sep 2024 | 894.4 | 905 | 922 | 884.95 |
13 Sep 2024 | 883.05 | 890 | 919.95 | 870.4 |
12 Sep 2024 | 892.6 | 892.5 | 908.75 | 880.05 |
11 Sep 2024 | 877.5 | 854.7 | 903.7 | 836.05 |
10 Sep 2024 | 843.45 | 832.5 | 855.75 | 830.6 |
09 Sep 2024 | 831.9 | 824.85 | 846.95 | 815.05 |
06 Sep 2024 | 808.65 | 845.95 | 845.95 | 797 |
Date | Price |
---|---|
19 Sep 2024 | 847.35 |
18 Sep 2024 | 904.6 |
17 Sep 2024 | 891.8 |
16 Sep 2024 | 894.4 |
13 Sep 2024 | 883.05 |
12 Sep 2024 | 892.6 |
11 Sep 2024 | 877.5 |
10 Sep 2024 | 843.45 |
09 Sep 2024 | 831.9 |
06 Sep 2024 | 808.65 |
Shilpa Biologicals appoints CEO
Shilpa Medicare announced the appointment of Dr. Sridevi Khambhampaty, as Chief Executive ...
Read more
19 Sep 202413:35
Shilpa Medicare arm appoints Sridevi Khambhampaty as CEO
Sridevi Khambhampaty y is a recognized leader in the Biologics industry with over two deca...
Read more
19 Sep 202413:35
Shilpa Medicare update on its CDMO customer - Unicycive Therapeutics
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) announced the submission of NDA to U.S. FDA fo...
Read more
04 Sep 202415:14
Shilpa Medicare hits life high on submission of new drug application to USFDA
The said drug is used for treatment of hyperphosphatemia in patients with chronic kidney d...
Read more
04 Sep 202415:24
Shilpa Medicare hits record high on USFDA nod for cancer drug
The said product is the first liquid injection for Bortezomib, approved for both subcutane...
Read more
27 Aug 202414:43
Shilpa Medicare successfully completes phase-3 clinical studies of NorUDCA
Shilpa Medicare has successfully completed phase-3 clinical studies of its novel product S...
Read more
26 Aug 202410:30
FAQs for EPS of Shilpa Medicare Ltd
On what factors does the shareholding pattern of Shilpa Medicare Ltd change frequently?
How often is Shilpa Medicare Ltd's shareholding pattern updated?
What categories are included in the shareholding pattern of Shilpa Medicare Ltd?
Why is the shareholding pattern of Shilpa Medicare Ltd important for investors?
Where can I find the latest shareholding pattern of Shilpa Medicare Ltd?
Unlimited trading at just
Rs. 199*